Actinium Pharmaceuticals, Inc. (ATNM:NYSEMKT) soared at $6.56, a gain of 24%. On Mon, Apr 11, 2022, ATNM:NYSEMKT hit a New 2-Week Intraday High of $5.49. The stock appeared on our News Catalysts scanner on Tue, Apr 12, 2022 at 09:22 AM in the 'AGREEMENT' category. From Mon, Mar 28, 2022, the stock recorded 80.00% Up Days and 63.64% Green Days
The share price of the company has been moving sideways in recent weeks.
About Actinium Pharmaceuticals, Inc. (ATNM:NYSEMKT)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's product portfolio includes Iomab-B and Actimab-A.
Top 10 Gainers:
- PolarityTE, Inc. (PTE:NASDAQ), 82.97%
- Histogen Inc. (HSTO:NASDAQ), 67.78%
- Qualigen Therapeutics Inc. (QLGN:NASDAQ), 53.62%
- Agile Therapeutics, Inc. (AGRX:NASDAQ), 47.18%
- TROOPS Inc. (TROO:NASDAQ), 31.29%
- Vertical Aerospace Ltd. (EVTL:NYSE), 30.93%
- MiNK Therapeutics Inc. (INKT:NASDAQ), 28.74%
- Actinium Pharmaceuticals, Inc. (ATNM:NYSEMKT), 24.01%
- Aterian Inc. (ATER:NASDAQ), 23.76%
- Poema Global Holdings Corp. (PPGH:NASDAQ), 23.69%